OR6C73P

Across TCGA pan-cancer cohorts, OR6C73P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR6C73P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher OR6C73P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated OR6C73P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ESCA, KIRC, and BRCA are the cancer types where OR6C73P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	III,IV	0.579	0.263	.020	69	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
BRCA	OS	Tertile	All	0.117	0.578	.009	36	view →
LUAD	OS	Tertile	All	0.235	0.788	.005	36	view →
HNSC	DFS	Tertile	II,III,IV	0.158	0.667	.001	27	view →
GBM	OS	Tertile	All	0.121	0.415	.042	9	view →
SARC	OS	Tertile	All	0.175	0.730	.009	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR6C73P–ESCA (DFS)

Open the ESCA breakdown →